Category Archives: EUFEMED

Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away

Posted On 10-May-2017 by Steffan Stringer

Joint Meeting of European Human Pharmacological Societies 17 May – 19 May, 2017, London You still have time to register for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management. The Faculty of Pharmaceutical Medicine has approved this event … Continue reading →

Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away

Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open

Posted On 5-Dec-2016 by Steffan Stringer

Registration for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management has now opened. Members of AHPPI get substantial savings on the non-member prices ranging from £37 (early-bird workshop only) to £103.20 (early-bird workshop and conference) when including … Continue reading →

Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open

EUFEMED Clinical Pharmacology Conference, London, May 2017 – Web site goes live!

Posted On 30-Nov-2016 by Steffan Stringer

Letter from the President: Dear Colleague, On behalf of the Organising and Scientific Committees it is our great pleasure to welcome you to the 1st conference of the European Federation for Exploratory Medicines Development (EUFEMED), to be held from May 18 – 19, … Continue reading →

Comments Off on EUFEMED Clinical Pharmacology Conference, London, May 2017 – Web site goes live!

Exploratory medicines development – Innovation and risk management

Posted On 19-Oct-2016 by Steffan Stringer

First EUFEMED Conference Joint Meeting of European Human Pharmacological Societies Wednesday 17 May – Friday 19 May, 2017, London/UK Assessment and mitigation of risk are most challenging in exploratory drug development when a promising new compound is to be characterised … Continue reading →

Comments Off on Exploratory medicines development – Innovation and risk management